In the last trading session, 1.21 million RXO Inc (NYSE:RXO) shares changed hands as the company’s beta touched 1.61. With the company’s per share price at $13.48 changed hands at -$0.61 or -4.33% during last session, the market valuation stood at $2.21B. RXO’s last price was a discount, traded about -143.47% off its 52-week high of $32.82. The share price had its 52-week low at $12.19, which suggests the last value was 9.57% up since then. When we look at RXO Inc’s average trading volume, we note the 10-day average is 2.04 million shares, with the 3-month average coming to 1.61 million.
Analysts gave the RXO Inc (RXO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.95. If we narrow down to specifics, the data shows that 3 out of 25 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 8 recommended RXO as a Hold, 13 felt it is a Buy and 0 rated the stock as Underweight. RXO Inc’s EPS for the current quarter is expected to be -0.02.
RXO Inc (NYSE:RXO) trade information
Instantly RXO was in red as seen at the end of in last trading. With action 1.81%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -43.46%, with the 5-day performance at 1.81% in the green. However, in the 30-day time frame, RXO Inc (NYSE:RXO) is -29.24% down. Looking at the short shares, we see there were 8.15 million shares sold at short interest cover period of 4.91 days.
The consensus price target for the stock as assigned by Wall Street analysts is 23.5, meaning bulls need an upside of 42.64% from its current market value. According to analyst projections, RXO’s forecast low is 19 with 29 as the target high. To hit the forecast high, the stock’s price needs a -115.13% plunge from its current level, while the stock would need to soar -40.95% for it to hit the projected low.
RXO Inc (RXO) estimates and forecasts
Year-over-year growth is forecast to reach 41.79% up from the last financial year.
Consensus estimates given by 14 financial analysts project the company’s revenue in the current quarter to hit an average of 1.49B. 14 analysts are of the opinion that RXO Inc’s revenue for the current quarter will be 1.55B. The company’s revenue for the corresponding quarters a year ago was 913M and 930M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 63.57%. The estimates for the next quarter sales put growth at 66.25%.
The 2025 estimates are for RXO Inc earnings to increase by 78.58%, but the outlook for the next 5-year period is at 97.98% per year.
RXO Dividends
RXO Inc is expected to release its next quarterly earnings report on 2025-Feb-04.
RXO Inc (NYSE:RXO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.25% of RXO Inc shares while 107.77% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 109.13%. There are 107.77% institutions holding the RXO Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 15.1802% of the shares, roughly 17.85 million RXO shares worth $466.74 million.
ORBIS ALLAN GRAY LTD holds the second largest percentage of outstanding shares, with 15.1266% or 17.79 million shares worth $465.1 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 8.76 shares estimated at $118.09 million under it, the former controlled 5.34% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 3.08% of the shares, roughly 5.06 shares worth around $68.16 million.
